GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc. (GPCR) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.50 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Structure Therapeutics Inc.
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.
Sector
Healthcare
Industry
Biotechnology